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Abstract
Background: Laparoscopic distal pancreatectomy (LDP) showed advantage of perioperation outcomes for benign
and low-grade tumor of the pancreas. The application of LDP for pancreatic ductal adenocarcinoma (PDAC) didn’t
gain popular acceptance and the number of LDP for PDAC remains low. We designed a case-matched study to
analysis the short- and long-term outcomes of the patients undergoing either Laparoscopic distal pancreatectomy
or open distal pancreatectomy for PDAC.
Method: From 2003 to 2013, 17 patients were underwent LDP and 34 patients were underwent ODP for PDAC
were matched by tumor size, age and body mass index (BMI). The two groups’ demographic information,
perioperative outcomes and survival data were compared.
Results: Baseline characteristics were comparable between the LDP and ODP groups. The intraoperative blood loss,
first flatus, first oral intake and postoperative hospital stay were significantly less in LDP group than ODP group
(50 ml vs400ml, P = 0.000; 3d vs 4d, P = 0.001; 3d vs 4d, P = 0.003; 13d vs 15.5d, P = 0.022). The mean operation time,
overall postoperative morbidity and postoperative pancreatic fistula rates were similar in the two groups. 5 patients
(29.4 %) in LDP group and 7 patients (20.6 %) in ODP group underwent extended resections. There were no
significant differences in tumor sizes (3.5 cm vs 3.9 cm, P = 0.664) and number of harvested lymph nodes (9 vs8
P = 0.534). The median overall survival for both groups was 14.0 months. Cox proportional hazards analysis showed
extended resections, R1 resection, perineural invasion and tumor differentiation were associated with worse survival.
Conclusion: LDP is technically feasible and safe for PDAC in selected patients and the short-term oncologic
outcomes were not inferior to ODP in this small sample study. However the long-term oncologic safety of LDP for
PDAC has to be further evaluated by multicenter or randomized controlled trials.
Keywords: Pancreatic ductal adenocarcinoma, Laparoscopic surgery, Open surgery, Distal pancreatectomy, Case
matched study
Background
In the last few decades, with the development of laparo-
scopic instruments and skills, Laparoscopic distal pancrea-
tectomy (LDP) has become widely accepted by surgeons
for benign and low-grade tumors of the pancreas. Recent
reviews and meta-analysis showed that LDP has the ad-
vantage of less blood loss and fewer hospital stay days as
well as fewer postoperative complications compared with
open distal pancreatectomy [1–3]. However, application of
laparoscopic approach has been restricted for malignant
pancreatic lesions due to concerns over oncologic safety
[4]. Unlike other gastrointestinal regions, such as stomach
and colon, until now, only a few pioneer studies reported
direct comparisons of oncologic outcomes between LDP
and open distal pancreatectomy (ODP) for pancreatic
ductal adenocarcinoma (PDAC) [5–9]. In this study, we
designed a 1:2 case-matched retrospective study from a
single institution and analysed the short-term and long-
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term outcomes of the patients undergoing either LDP or
ODP for PDAC.
Methods
Patient sample and data collection
From April 2003 to December 2013, 68 distal pancrea-
tectomies were performed for PDAC. All the patients
were given detailed information about LDP and OPD for
PDAC, four experienced surgeons decided the type of
operation according to patient’s condition with informed
consent. An informed consent was signed by every pa-
tient before the study. The exclusion criterias for
LDPwere: (1) borderline resectable according to NCCN
guidelines [10]; (2) intra-abdominal dissemination; (3)
tumor size > 5 cm (located in pancreatic body) or >10 cm
(located in pancreatic tail). Invasion of adjacent organs
were not considered as contraindications. Cases who
underwent laparoscopic exploration before definitive open
surgery were not included in either LDP or ODP groups.
Finally 17 LDP cases were enrolled in this study and were
matched with 34 ODP cases in a 1:2 case-matched design.
The patients were matched by three parameters: tumor
size (±0.5 cm), age (±5 years), BMI (±1.0). The study was
approved by the Institutional Review Board of Sir Run
Run Shaw Hosptial of Zhejiang University. All patient data
were retrospectively reviewed from cohort database in-
cluding demographic information, perioperative outcomes
and survival data. The following data were collected: gen-
der, age, American Society of Anesthesiologists (ASA),
body mass index (BMI), comorbidity, operation time,
intraoperative blood loss (EBL), resection margin sta-
tus, length of hospital stay, postoperative pancreatic
fistulae (POPF), postoperative complications, mortal-
ity, adjuvant therapy, recurrence, tumor size, tumor
differentitation, tumor stage, number of harvested
lymph nodes and ration of N1.
Operative technique
Laparoscopic pancreatic surgery has been carried at our
institution since 2003. The first LDP for PDAC was per-
formed in 2004. The standardized technique for LDP at
our institution has been previously described [11, 12].
The first 10-mm trocar was inserted below the umbil-
icus, then the main working trocar (12 mm) and another
three assistant trocars (5 mm) were inserted into the
right upper flank, left upper flank, left flank, and right
flank quadrants respectively; these five trocars were ar-
ranged in a V-shape. Briefly, the gastrocolic ligament was
divided by a harmonic scalpel (Harmonic Ace; Ethicon
Endo-Surgery, Cincinnati, OH, United States) and the
lesser sac was entered. Then, the superior border of the
pancreas was mobilized and the proximal splenic artery
was freed. After mobilization of the inferior border of the
pancreas, a retropancreatic tunnel was created under the
neck of the pancreas and the pancreas was transected
using an endoscopic linear stapler (Endocutter 60 stapler,
white or blue cartridge; Ethicon Endo-Surgery, Cincinnati,
OH, United States). The splenic artery and the splenic
vein were divided at the root. The soft tissue around the
common hepatic artery and the celiac trunk were dis-
sected. Then dissection was performed in a “medial – to -
lateral” fashion and the distal pancreas along with the
spleen were removed. In cases of invasion to adjacent or-
gans such as stomach, left adrenal gland and even left lobe
of liver, en bloc resection was performed by laparoscopic
approach. The resected specimen was removed using an
endoscopic bag by enlarging the incision at the periumbili-
cal port. ODP was performed in a traditional manner or
same method as LDP depending on the habit of the sur-
geon. Frozen section biopsy was applied to ascertain the
resection margin.
Postoperative management Oral intake was started
after the first flatus passed. The gastric tube was re-
moved immediately after surgery and the urethral cath-
eter was removed on the following day. Patient were
discharged if they could tolerate semifluid diet without
obvious discomfort and they felt sufficiently recovered
without any major complications. Postoperative compli-
cations were recorded using the modified Clavien-Dindo
classification [13]. Mortality was defined as death occurring
during hospitalization or within 30 days. Postoperative pan-
creatic fistulae were defined as any measurable volume of
fluid output (amylase level three times greater than the nor-
mal serum level) from drainage tube on or after postopera-
tive day 3 according to the International Study Group on
(ISGPF) [14]. R1 resection was considered as tumor exten-
sion within 1 mm of margin [15]. TMN stage was applied
by the American Joint Committee on Cancer (7th edition).
Adjuvant therapy refers to use of motherapy or radiation
therapy perioperative or postoperative.
Patient follow-up
All patients were regularly followed up through out-
patient service at the 1, 3, 6, 12 months and 6-month in-
tervals thereafter by telephone call. Recurrences or
metastasis were recorded by evidence of imaging exam-
ination, laboratory tests or pathologic results from bi-
opsy, cytology or surgical resection. The last follow-up
was conducted in Feburary 2015.
Statistical analysis
Continuous variables were presented as median and
range and analyzed using the Student t test (parametric
distribution) or Mann–Whitney test (nonparametric dis-
tribution). Categorical variables were analyzed using Chi
Squared and or Fisher’s exact test. Kaplan-Meier method
with log rank testing was applied for estimating the
survival analysis. Cox proportional hazards analysis was
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applied to investigate the prognostic factor for overall
survival following distal pancreatectomy and variables
were entered into the multivariate regression analysis




The baseline characteristics of patients undergoing distal
pancreatectomy for PDAC are summarized at Table 1.
Seventeen patients underwent LDP while 34 patients
underwent ODP. Of the 17 patients in LDP group 2
cases (11.8 %) were converted to open procedure be-
cause of local invasion of superior mesenteric artery.
The baseline characteristics such as age, gender, BMI,
ASA score, comorbidity and ration of extended resection
were comparable between LDP and ODP. The most
common comorbidity was hypertension and diabetes
mellitus (DM).
Comparison of surgical outcomes for PDAC
Comparison of surgical outcomes of distal pancreatec-
tomy for PDAC is summarized in Table 2. The mean op-
eration time in LDP group and ODP group was similar
(190 min vs 245 min, P = 0.064). The intraoperative
blood loss was significantly lower in LDP group than in
ODP group (50 ml vs 400 ml, P = 0.000). The first flatus
time and diet start time were shorter in LDP group (3d
vs 4d, P = 0.001; 3d vs 4d, P = 0.003). The postoperative
length of hospital stay was shorter in LDP group (13d vs
15.5d, P = 0.022).
In LDP group 5 patients underwent extended distal
pancreatectomy, including resection of stomach in 1 pa-
tient, left hepatic lobe in 2 patients and left adrenal
gland in 3 patients (in 1 patient both left hepatic lobe
and left adrenal gland were resected); while in ODP
group, 7 patients had simultaneous resections, including
stomach in 1 patient, colon in 1 patient, partial resection
portal vein in 1 patient, left hepatic lobe in 2 patients,
left adrenal gland in 3 patients (in 1 patient both left
hepatic lobe and left adrenal gland were resected). There
was one R1 resection in LDP group and five R1 resec-
tion in ODP group and showed no significant differences
between the two groups (P = 0.650).
There were no significant differences in overall postop-
erative morbidity rate between the two groups (P = 0.750).
Postoperative pancreatic fistula rates were similar in the
two groups (P = 0.484) and no C-grade record in LDP
group. Only one patient needed reoperation because of in-
testinal obstruction in ODP group. One death occurred
35 days post-operation during the hospitalization in ODP
group. ODP group had 2 (5.9 %) 30 day re-admission be-
cause of abdominal infection while LDP group had none
(P = 0.547).
Comparison of clinicopathologic characteristics
Comparison of clinicopathologic characteristics of
LDP and ODP for PDAC is shown in Table 3. There
were no significant differences in tumor sizes (3.5 cm
vs 3.9 cm, P = 0.664), number of harvested lymph
nodes (9 vs 8 P = 0.534), ration of N1 (P = 0.382),
Table 1 Baseline characteristics of patients undergoing distal
pancreatectomy for PDAC
Characteristics LDP (n = 17) ODP (n = 34) P value
Age 60 (44–75) 64 (40–76) 0.164
Gender (F) 6 (35.3) 15 (44.1) 0.763
BMI 23.4 (18.7–27.6) 23.7 (19.0–28.7) 0.313
ASA score 0.569
1 9 (52.9) 15 (44.1)
2 8 (47.1) 19 (55.9)
Comorbidity 7 (41.2) 17 (48.6) 0.769
Extended resection 5 (29.4) 7 (20.6) 0.792
Liver 2 (11.8) 2 (5.9)
Left adrenal gland 3 (17.6) 3 (8.8)
Stomach 1 (5.9) 1 (2.9)
Colon 0 (0) 1 (2.9)
Portal vein 0 (0) 1 (2.9)
Table 2 Comparison of surgical outcomes of distal
pancreatectomy for PDAC
Variables LDP (n = 17) ODP (n = 34) P value
Operation time (min) 190 (100–390) 245 (155–420) 0.064
Intraoperative blood loss (mL) 50 (30–500) 400 (100–3900) 0.000
First flatus time (d) 3 (1–4) 4 (2–6) 0.001
First oral intake (d) 3 (1–6) 4 (2–9) 0.003
Pancreatic fistula 0.484
Grade A 6 (35.3) 6 (17.6)
Grade B 3 (17.6) 9 (26.5)
Grade C 0 (0) 1 (2.9)
Clavien-Dindo grade 0.754
Grade I 3 (17.6) 4 (11.8)
Grade II 3 (17.6) 7 (20.6)
Grade III 0 (0) 2 (5.9)
Grade IV 0 (0) 0 (0)
grade V 0 (0) 1 (2.9)
Resection margin 0.650
R0 16 (94.1) 29 (85.3)
R1 1 (5.9) 5 (14.7)
Postoperative hospital stay (d) 13 (4–23) 15.5 (6–40) 0.022
30 day re-admission 0 (0) 2 (5.9) 0.547
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perineural invasion (P = 1.000), recurrences (P = 1.000).
Most patients in both groups had T3 disease. LDP group
had 2 (3.9 %) T4 cases. There was no significant dif-
ference between the two groups in terms of tumor stage
(P = 0.090) as well as tumor differentiation (P = 0.145).
The ration of accepting adjuvant chemotherapy was simi-
lar in two groups (P = 1.000).
Survival
The mean and median overall survival for the LDP
group was 19.9 months and 14.0 months and for ODP
group was 22.3 months and 14.0 months. There was
no difference in overall survival between the two
groups (P = 0.802) (Fig. 1). In Cox proportional haz-
ards analysis, tumor size, comorbidity, POPF, tumor
stage and adjuvant treatment were not significant for
overall survival. Extended resections, R1 resection,
perineural invasion and tumor differentitation (Mod-
erate) were associated with worse survival following
distal pancreatectomy and the choice of surgical pro-
cedure was not associated with the overall survival
(Table 4). The mean and median overall survival for
group with adjuvant treatment was 27.8 months and
15.0 months while the group without adjuvant treat-
ment was 16.6 months and 13.0 months (P = 0.363).
The median survival for extended resection group
was 8.0 months and for no extended resection group
was 15.0 months (P = 0.004) (Fig. 2).
Discussion
In recent years, LDP has been gradually accepted as
standard approach to treat benign or low grade lesions
located in the body or tail of the pancreas. The technical
feasibility, safety and clinical benefit has been well con-
firmed by various matched studies compared with open
distal pancreatectomies [16–18]. However, application of
Laparoscopic distal pancreatectomies for PDAC was still
limited due to the concern of oncologic outcome and
surgical quality [4]. But reports emerging from some
experienced centers are encouraging. Compared with
conventional open approach, they demonstrated the ad-
vantages of less blood loss, shorter hospital stay and
early return to normal activity with a similar morbidity,
POPF, short oncology outcome (R0 resection rate, the
number of harvested lymph nodes) and the overall sur-
vival rate [5–9, 19, 20]. In this case-matched study we
compared the short-term and long-term outcomes of pa-
tients undergoing distal pancreatectomy and the results
were consistent with these reports.
Surgery remains the only opportunity for long-term
survival for patients with resectable PDAC [21]. R0 re-
section is the most crucial prognostic factor [22]. In a
multicenter analysis Kooby et al. [5] reported that the
R0 resection rate of LDP and ODP for PDAC was 73.9 %
(17/23) and 65.7 % (46/70). A multivariate analysis was
conducted in the whole cohort and only blood >500 ml
was associated with R1 resection while the method of re-
section (LDP or ODP) wasn’t correlated. Shin et al. [20]
reported the largest single-institution study of LDP for
PDAC (n = 70), the R0 resection rate was 75.7 % (53/70)
for LDP while 83.8 % (67/80) for ODP. Lee et al. and Hu
et al. [8, 9] reported in their series that patients included
in LDP group were relatively in early stage and the R0 re-
section rate was 100 %. These case–control retrospective
studies showed no significant difference of R0 resection
between the LDP and ODP groups. In the present study,
the R0 resections for LDP and ODP were 94.1 % and
85.3 % (P = 0.650) which was in accordance with those
former studies. Recently, Sharpe et al. [19] reported out-
comes for 769 patients of which 144 in the LDP group for
PDAC through the National Cancer Data Base. In this
retrospective survey, the LDP group had a decrease in
margin positivity rate but the tumor size was smaller com-
pared with the ODP group and LDP was more likely to be
performed at academic/research institutions. The results
were satisfactory for laparoscopic procedure although the
heterogeneity might exist due to the type of study design
or selection bias. Besides the essentiality of frozen section,
extended resections were required in some cases in order
for a definitive margin-negative surgery because of the ag-
gressive nature of the disease [23]. Extended resections
are feasible procedures with increased postoperative mor-
bidity and better survival compared with palliative bypass
procedures [24]. Although laparoscopic extended resec-
tion of the pancreas is technically demanding, its applica-
tion is increasing in specialized centers. Croome et al. [25]
Table 3 Comparison of Clinicopathologic Characteristics of
distal pancreatectomy for PDAC
Variables LDP (n = 17) ODP (n = 34) P value
Tumor size (cm) 3.5 (2.3–5.5) 3.9 (1.8–5.5) 0.664
Tumor stage 0.090
T1 0 (0) 0 (0)
T2 3 (17.6) 4 (11.8)
T3 12 (70.6) 30 (88.2)
T4 2 (3.9) 0 (0)
Total LN 9 (5–15) 8 (2–22) 0.534
N1 (positive) 7 (41.2) 19 (55.9) 0.382
Tumor differentitation 0.145
Well 3 (17.6) 7 (23.5)
Moderate 6 (35.3) 19 (55.9)
Poor 8 (47.1) 8 (20.6)
Perineural invasion 12 (70.6) 25 (29.4) 1.000
Adjuvant treatment 13 (76.5) 26 (76.5) 1.000
Recurrences 11 (64.7) 16 (47.1) 0.372
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reported data from Mayo clinic of 31 patients undergoing
total laparoscopic pancreaticoduodenectomy with major
vascular resection, there was no significant difference of
the total complications comparable with open group and
with less mean operative blood, less hospital stay. We pre-
viously reported the first laparoscopic hepatopancreato-
duodenectomy case with favorable perioperative outcome
and showed no sign of recurrence over a year [26]. The
data of LDP combined with extended resections is rare.
Shin et al. [20] reported 6 (8.6 %) cases of concurrent re-
sections for PDAC by laparoscopic procedure including 5
left colectomies and 1 gastrectomy. After propensity
score-matched (including age, BMI, tumor size, concur-
rent resection) analysis, the overall survival was similar be-
tween the LDP group and ODP group while concurrent
resection ration were balanced between the two groups.
Ricci et al. [27] reported 6 (18.7 %) extended resections in-
cluding resection of liver wedge, stomach, left adrenal
gland and colon among 32 LDP. In our study, we had 5
cases (29.4 %) of extended resections in LDP group with 1
Fig. 1 Kaplan-Meier curve of overall survival for LDP and ODP
Table 4 Cox proportional hazards analysis for overall survival
Viables Hazard ration 95 % CI P value
Adjuvant treatment (no/yes) 0.407 0.207–1.020 0.056
R 1 (negative/positive) 1.260–15.468 0.020
Extended resection (no/yes) 1.105–5.945 0.028
Operation (LDP/ODP) 0.420–1.863 0.885




Tumor stage T2 1.000
Tumor stage T3 0.776 0.292–2.060 0.611
Tumor stage T4 1.174 0.433–3.180 0.753
Tumor differentitation Well 1.000
Tumor differentitation Moderate 3.432 1.012–11.645 0.048
Tumor differentitation Poor 6.316 0.980–40.700 0.053
HR hazard ratio
95 % CI, 95 % confidence interval
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R1 resection while 7 cases (20.6 %) in ODP group with 5
R1 resections. We abolished the laparoscopic procedure
of two cases because of invasion to superior mesenteric
artery (SMA). Despite the sample data was too small to
make any persuasive conclusion, it may achieve R0 resec-
tion of locally advanced PDAC in selected patients
through laparoscopic procedure by skilled surgeons. Com-
pletion of the learning curve, a fixed surgical group and
suitable selection criteria were efficacious to carry out
these complex goals [27, 28] and we insist on using 5 tro-
cars strategy in order for the cooperation of the main sur-
geon and the first assistant. Until now, there is no
standard indication of LDP for PDAC. As reported from
previous studies and meta-analysis, surgeons are mostly
inclined to conduct LDP for smaller tumor size [2, 6–8].
Although Kooby et al. [5] reported tumor size (>4 cm)
was not associated with positive resection margin, a huge
tumor would be an obvious obstacle for exposure of the
operation field. So, patients forwith tumor size >5 cm in
body and >10 cm in tail of the pancreas were reserved for
open procedure and were exluded in this study. The me-
dian survival was both 14 months in LDP and ODP
groups in this series. Kooby et al. [5] reported median sur-
vival 16 months both for LDP and ODP groups and
Magge et al. [6] reported 19 months for the entire cohort.
Lee et al. [8] reported a median follow-up 39 months for
the minimally invasive surgery group (including 4 robotic
cases) using their inclusion criteria (Yonsei criteria) which
mainly consisted of early stage pancreatic cancer. Com-
pared with previous studies, the survival data in this study
was not fulfilling. In Cox proportional hazards analysis ex-
tended resection, perineural invasion were strong factors
for worse survival. The high ration of extended resection
(23.5 %) and perineural invasion (72.5 %) of the whole co-
hort indicated the cases enrolled in this study were rela-
tively in advanced stage due to lack of early diagnosis of
the disease probably. The median survival for no extended
resection group was 15.0 months and was consistent with
the previous case-matched studies.
This study has several critical limitations, including
the retrospective design and low number of patients en-
rolled in the study. Adjuvant treatment is believed to
prolong overall survival [29], but in this study the Cox
proportional hazards analysis showed no association
Fig. 2 Kaplan-Meier curve of overall survival for extended resection group and no extended group
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with overall survival (P = 0.380). The poor differentiation
was not associated with overall survival but the moder-
ate differentiation showed association. The small sample
of this study might be the reason and didn’t have suffi-
cient statistical power to evaluate the outcome. The
study span lasted 11 years and only 1.3 LDP cases per
year were performed. The surgical technique was not
standardized between the laparoscopic and open ap-
proach. Also the follow-up time was short especially for
the LDP group and it was difficult to calculate the 5-
year survival. Until now, the oncologic safety and long-
term survival were not tested by any randomized con-
trolled study between LDP and ODP for PDAC, so it is
not sufficient enough to make a conclusion that LDP is
oncologic equivalence to ODP [3, 4]. As Kooby and
Kang commented it was difficult to conduct an RCT be-
cause of the infrequence of diagnosis and opportunity
for operation of PDAC in the pancreatic body and tail
[4, 5]. The result of this study could provide valuable
evidence to support use of LDP for PDAC even in rela-
tively advanced stage.
Conclusion
In conclusion, the results in our study validated that
LDP was technically feasible and safe for PDAC in se-
lected patients and the short-term oncologic outcomes
were not inferior to ODP in this small sample study
However the long-term oncologic safety of LDP for
PDAC has to be further evaluated by multicenter or ran-
domized controlled trials.LDP with extended resection
for PDAC is better performed in highly specialized cen-
ters and with suitable selection criteria.
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